2008-06-Members Alert
June 1, 2008 – June 2008 PDF And another thing The allergy and asthma drug Singulair is undergoing an FDA safety review after reports of behavioral changes (mood swings, depression, anxiety, tremors, and even suicide) were linked to the popular drug. Ten years after Singulair was originally approved by the FDA, and eight years... Read More >


